openPR Logo
Press release

Cold Agglutinin Disease Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight

01-22-2025 03:46 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Cold Agglutinin Disease Pipeline

Cold Agglutinin Disease Pipeline

Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cold Agglutinin Disease pipeline constitutes 5+ key companies continuously working towards developing 5+ Cold Agglutinin Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Cold Agglutinin Disease Pipeline Insight" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cold Agglutinin Disease Market.

The Cold Agglutinin Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Request for sample report @ https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key takeaways from the Cold Agglutinin Disease Pipeline Report:
• Cold Agglutinin Disease Companies across the globe are diligently working toward developing novel Cold Agglutinin Disease treatment therapies with a considerable amount of success over the years.
• Cold Agglutinin Disease companies working in the treatment market are Apellis Pharmaceuticals, Novartis, Incyte corporation, Sanofi, Alexion Pharmaceuticals, Novartis, and others, are developing therapies for the Cold Agglutinin Disease treatment
• Emerging Cold Agglutinin Disease therapies in the different phases of clinical trials are- Pegcetacoplan, Iptacopan, Parsaclisib, SAR445088, Eculizumab, sutimlimab (BIVV009, Iptacopan, and others are expected to have a significant impact on the Cold Agglutinin Disease market in the coming years.
• In March 2024, Alpine Immune Sciences, Inc. has initiated the RUBY-4 (NCT05757570) study, a multi-cohort, open-label Phase 1b trial evaluating povetacicept in immune thrombocytopenia, autoimmune hemolytic anemia, and cold agglutinin disease. In this study, povetacicept is administered subcutaneously for up to 48 weeks. Key endpoints include blood cell counts, durable responses, and levels of disease-related autoantibodies.

Cold Agglutinin Disease Overview
Cold Agglutinin Disease (CAD) is a rare autoimmune disorder in which the immune system produces antibodies, called cold agglutinins, that mistakenly target and destroy red blood cells at low temperatures. This leads to a type of anemia called hemolytic anemia.

Get a Free Sample PDF Report to know more about Cold Agglutinin Disease Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Emerging Cold Agglutinin Disease Drugs Under Different Phases of Clinical Development Include:
• Pegcetacoplan: Apellis Pharmaceuticals
• Iptacopan: Novartis
• Parsaclisib: Incyte corporation
• SAR445088: Sanofi
• Eculizumab: Alexion Pharmaceuticals
• sutimlimab (BIVV009): Sanofi
• Iptacopan: Novartis

Cold Agglutinin Disease Route of Administration
Cold Agglutinin Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Cold Agglutinin Disease Molecule Type
Cold Agglutinin Disease Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Cold Agglutinin Disease Pipeline Therapeutics Assessment
• Cold Agglutinin Disease Assessment by Product Type
• Cold Agglutinin Disease By Stage and Product Type
• Cold Agglutinin Disease Assessment by Route of Administration
• Cold Agglutinin Disease By Stage and Route of Administration
• Cold Agglutinin Disease Assessment by Molecule Type
• Cold Agglutinin Disease by Stage and Molecule Type

DelveInsight's Cold Agglutinin Disease Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Cold Agglutinin Disease product details are provided in the report. Download the Cold Agglutinin Disease pipeline report to learn more about the emerging Cold Agglutinin Disease therapies at:
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key companies in the Cold Agglutinin Disease Therapeutics Market include:
Key companies developing therapies for Cold Agglutinin Disease are - Sanofi, Bioverativ, Sobi, Apellis Pharmaceuticals, Novartis, Incyte Corporation, and others.

Cold Agglutinin Disease Pipeline Analysis:
The Cold Agglutinin Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Cold Agglutinin Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cold Agglutinin Disease Treatment.
• Cold Agglutinin Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cold Agglutinin Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cold Agglutinin Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Cold Agglutinin Disease drugs and therapies-
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cold Agglutinin Disease Pipeline Market Drivers
• Several organizations and companies like Cold agglutinin disease foundation and Sanofi Genzyme are raising awareness about the disease which can lead to increased patient pool.

Cold Agglutinin Disease Pipeline Market Barriers
• Mild anemic patients because of CAD don't have such a pharmaceutical treatment option, so there is an unsaid need for the drugs in mild anemic patients.

Scope of Cold Agglutinin Disease Pipeline Drug Insight
• Coverage: Global
• Key Cold Agglutinin Disease Companies: Apellis Pharmaceuticals, Novartis, Incyte corporation, Sanofi, Alexion Pharmaceuticals, Novartis, and others
• Key Cold Agglutinin Disease Therapies: Pegcetacoplan, Iptacopan, Parsaclisib, SAR445088, Eculizumab, sutimlimab (BIVV009, Iptacopan, and others
• Cold Agglutinin Disease Therapeutic Assessment: Cold Agglutinin Disease current marketed and Cold Agglutinin Disease emerging therapies
• Cold Agglutinin Disease Market Dynamics: Cold Agglutinin Disease market drivers and Cold Agglutinin Disease market barriers

Request for Sample PDF Report for Cold Agglutinin Disease Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Cold Agglutinin Disease Report Introduction
2. Cold Agglutinin Disease Executive Summary
3. Cold Agglutinin Disease Overview
4. Cold Agglutinin Disease- Analytical Perspective In-depth Commercial Assessment
5. Cold Agglutinin Disease Pipeline Therapeutics
6. Cold Agglutinin Disease Late Stage Products (Phase II/III)
7. Cold Agglutinin Disease Mid Stage Products (Phase II)
8. Cold Agglutinin Disease Early Stage Products (Phase I)
9. Cold Agglutinin Disease Preclinical Stage Products
10. Cold Agglutinin Disease Therapeutics Assessment
11. Cold Agglutinin Disease Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Cold Agglutinin Disease Key Companies
14. Cold Agglutinin Disease Key Products
15. Cold Agglutinin Disease Unmet Needs
16 . Cold Agglutinin Disease Market Drivers and Barriers
17. Cold Agglutinin Disease Future Perspectives and Conclusion
18. Cold Agglutinin Disease Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Cold Agglutinin Disease Market https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's 'Cold Agglutinin Disease Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Cold Agglutinin Disease Epidemiology https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's 'Cold Agglutinin Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Trending Reports:
• Adrenal Cortex Neoplasms Market: https://www.delveinsight.com/report-store/adrenocortical-carcinoma-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Pharma Licensing Services: https://www.delveinsight.com/consulting/licensing-services
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Bronchopulmonary Dysplasia Market: https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
• Burkitt Lymphoma Market: https://www.delveinsight.com/report-store/burkitt-lymphoma-market
• Chronic Rhinosinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-market
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Febrile Neutropenia Market: https://www.delveinsight.com/report-store/febrile-neutropenia-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Non-st Segment Elevation Acute Coronary Syndromes Market: https://www.delveinsight.com/report-store/non-st-segment-elevation-acute-coronary-syndromes-nste-acss-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Walking Impairment In Multiple Sclerosis Market: https://www.delveinsight.com/report-store/walking-impairment-in-multiple-sclerosis-market
• Acute On Liver Failure Market: https://www.delveinsight.com/report-store/acute-liver-failure-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Anal Cancer Market: https://www.delveinsight.com/report-store/anal-cancer-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/
Case Study: https://www.delveinsight.com/case-study/conference-intelligence-product-assessment

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cold Agglutinin Disease Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight here

News-ID: 3826200 • Views:

More Releases from DelveInsight Business Research

Autosomal Dominant Optic Atrophy Market Set for Robust Growth Through 2034, Driven by Severe Unmet Needs | DelveInsight
Autosomal Dominant Optic Atrophy Market Set for Robust Growth Through 2034, Driv …
The autosomal dominant optic atrophy treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and R&D in precision medicine from key pharmaceutical players, including PYC Therapeutics and Stoke Therapeutics, among others. DelveInsight's "Autosomal Dominant Optic Atrophy - Market Insight, Epidemiology And Market Forecast - 2034" report delivers an in-depth understanding of the ADOA treatment market, historical and forecasted epidemiology, as well as market trends across the US,
Severe Asthma Market Set for Robust Growth Through 2034, Driven by Breakthrough Biologics and Emerging Pipeline Therapies | DelveInsight
Severe Asthma Market Set for Robust Growth Through 2034, Driven by Breakthrough …
The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key pharmaceutical players, including AstraZeneca, GlaxoSmithKline, Amgen, Teva Pharmaceutical Industries, Novartis, Sanofi, Regeneron Pharmaceutical, Boehringer Ingelheim Pharmaceuticals, Kyorin Pharmaceutical, Pfizer, Chiesi Farmaceutici, AB Science, Avalo Therapeutics, and Theravance Biopharma, among others. DelveInsight's "Severe Asthma Market Insights, Epidemiology, and Market Forecast-2034" report delivers a comprehensive understanding of the severe asthma
Systemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting-Edge Therapies | DelveInsight
Systemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting …
The systemic lupus erythematosus (SLE) treatment pipeline is experiencing unprecedented expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, including Biogen, Idorsia Pharmaceuticals, AbbVie, BioSenic, Roche, Novartis, Allogene Therapeutics, Adicet Bio, and numerous other leading companies advancing innovative treatments through robust clinical development programs. DelveInsight's "Systemic Lupus Erythematosus Pipeline Insight, 2025" report delivers comprehensive insights about 120+ companies and 140+ pipeline drugs currently in the
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of 13.30% by 2032, Evaluates DelveInsight
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR

All 5 Releases


More Releases for Cold

Cold Chain Market Growth 2025 | Global Cold Storage & Logistics Trends, Top key …
Cold Chain Market, as analyzed in the study by DataM Intelligence, presents a detailed overview of the industry with in-depth insights, historical data, and key statistics. The report thoroughly examines market dynamics, competitive strategies, and major players, highlighting their product lines, pricing structures, financials, growth plans, and regional outreach. The Global Cold Chain Market ie estimated to reach at a CAGR of 9.28% during the forecast period 2024-2031. Get a Premium Sample
Cold Storage Construction Market Next Big Thing | Nichirei Logistics Group, Clov …
Latest Study on Industrial Growth of Cold Storage Construction Market 2023-2028. A detailed study accumulated to offer Latest insights about acute features of the Cold Storage Construction market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends
Cold Forming and Cold Heading Market SWOT analysis, Growth, Share, Size and Dema …
The global cold forming and cold heading market was valued at US$ 18.0 billion in 2021 and it is anticipated to grow up to US$ 31.0 billion by 2031, at a CAGR of 5.3% during the forecast period. New York, Global Cold Forming and Cold Heading Market report from Global Insight Services is the single authoritative source of intelligence on Cold Forming and Cold Heading Market . The report will provide
Indonesia Cold Chain Logistics Market : Cold Storage and Cold Chain Transport In …
According to a recent report published by Allied Market Research, titled, "Cold Chain Logistics Market by Business Type, End-Use Industry, Product, and Technology: Indonesia Opportunity Analysis and Industry Forecast, 2022-2031," the Indonesia cold chain logistics market was valued at $4.97 billion in 2021, and is projected to reach $12.59 billion by 2031, registering a CAGR of 10.2% from 2022 to 2031. Download Report Sample PDF : https://www.alliedmarketresearch.com/request-sample/4973 Indonesia cold chain logistics market
Global Cold chain Market Forecast to 2025 | Industry Analysis By Cloverleaf Cold …
The Global Cold Chain Market is expected to see progress in the coming period from 2018 to 2025 due to growing demand at the end-user level. In 2018-2025, the Global Cold Chain Market will establish monumental growth. Global Cold Chain Market Report also provides the latest developments and contracts awarded across different regions in the Global Blood Screening industry. Using the SWOT analysis, market drivers and constraints are detected. This
Cold Chain Monitoring Market to WItness Outstanding Growth | Cloverleaf Cold Sto …
The Executive outline consists of a comprehensive outline of the world Cold Chain Monitoring market. This comprehensive outline includes the general global Cold Chain Monitoring market outlook, and also the numerous trends within the supply and demand sides of the market. additionally, this section offers business growth-related recommendations and opportunities to appear forward to within the world Cold Chain Monitoring market. The forecast correlational analysis has been added at